Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TNFSF14 anticorps (AA 141-240) (PE)

TNFSF14 Reactivité: Souris, Rat WB, FACS Hôte: Lapin Polyclonal PE
N° du produit ABIN740635
  • Antigène Voir toutes TNFSF14 Anticorps
    TNFSF14 (Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
    Épitope
    • 15
    • 8
    • 6
    • 6
    • 6
    • 5
    • 4
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 141-240
    Reactivité
    • 57
    • 30
    • 22
    • 5
    • 4
    • 4
    • 1
    • 1
    Souris, Rat
    Hôte
    • 65
    • 15
    • 1
    Lapin
    Clonalité
    • 67
    • 14
    Polyclonal
    Conjugué
    • 28
    • 11
    • 9
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TNFSF14 est conjugé à/à la PE
    Application
    • 59
    • 30
    • 27
    • 13
    • 13
    • 12
    • 7
    • 6
    • 5
    • 5
    • 3
    • 3
    • 2
    Western Blotting (WB), Flow Cytometry (FACS)
     Réactivité croisée
    Souris, Rat
    Homologie
    Human,Dog,Cow,Pig,Horse,Rabbit
    Purification
    Purified by Protein A.
    Immunogène
    KLH conjugated synthetic peptide derived from human TNFSF14
    Isotype
    IgG
    Top Product
    Discover our top product TNFSF14 Anticorps primaire
  • Indications d'application
    FCM 1:20-100
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
    Date de péremption
    12 months
  • Sibilano, Gaudenzio, DeGorter, Reber, Hernandez, Starkl, Zurek, Tsai, Zahner, Montgomery, Roers, Kronenberg, Yu, Galli: "A TNFRSF14-FcɛRI-mast cell pathway contributes to development of multiple features of asthma pathology in mice." dans: Nature communications, Vol. 7, pp. 13696, (2016) (PubMed).

  • Antigène
    TNFSF14 (Tumor Necrosis Factor (Ligand) Superfamily, Member 14 (TNFSF14))
    Autre désignation
    TNFSF14 (TNFSF14 Produits)
    Synonymes
    anticorps TNFSF14, anticorps CD258, anticorps HVEML, anticorps LIGHT, anticorps LTg, anticorps TR2, anticorps HVEM-L, anticorps Ly113, anticorps TNF superfamily member 14, anticorps tumor necrosis factor (ligand) superfamily, member 14, anticorps TNFSF14, anticorps Tnfsf14
    Sujet

    Synonyms: LTg, TR2, CD258, HVEML, LIGHT, Tumor necrosis factor ligand superfamily member 14, Herpes virus entry mediator ligand, HVEM-L, Herpesvirus entry mediator ligand, TNFSF14, UNQ391/PRO726

    Background: Cytokine that binds to TNFRSF3/LTBR. Binding to the decoy receptor TNFRSF6B modulates its effects. Activates NFKB, stimulates the proliferation of T-cells, and inhibits growth of the adenocarcinoma HT-29. Acts as a receptor for Herpes simplex virus.

    ID gène
    8740
    UniProt
    O43557
    Pathways
    Cancer Immune Checkpoints
Vous êtes ici:
Support technique